This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
福泰製藥分析師發佈看好報告；以下爲週四的五大啓動
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
頂尖華爾街分析師改變對這些頂級股票的前景看法。如需全面了解所有分析師評級的變化，包括升級、降級和啓動，請參閱我們的分析師評級頁面。
- BMO Capital analyst Keith Tapper initiated coverage on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with an Outperform rating and announced a price target of $31. ACADIA Pharmaceuticals shares fell 0.6% to close at $15.50 on Wednesday. See how other analysts view this stock.
- Mizuho analyst Wei Fang initiated coverage on Grab Holdings Limited (NASDAQ:GRAB) with an Outperform rating and announced a price target of $5. Grab shares fell 0.3% to close at $3.51 on Wednesday. See how other analysts view this stock.
- Redburn Atlantic analyst Steve Chesney initiated coverage on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a Buy rating and announced a price target of $545. Vertex Pharmaceuticals shares rose 0.1% to settle at $474.00 on Wednesday. See how other analysts view this stock. See how other analysts view this stock.
- Stephens & Co. analyst Mason Carrico initiated coverage on Hologic, Inc. (NASDAQ:HOLX) with an Overweight rating and announced a price target of $87. Hologic shares gained 0.9% to close at $72.27 on Wednesday. See how other analysts view this stock.
- Oppenheimer analyst Ian Zaffino initiated coverage on Kyndryl Holdings, Inc. (NYSE:KD) with an Outperform rating and announced a price target of $33. Kyndryl shares fell 1% to settle at $25.28 on Wednesday. See how other analysts view this stock.
- BMO Capital分析師Keith Tapper發起了ACADIA Pharmaceuticals Inc.（納斯達克：ACAD）的覆蓋，給出了超額表現評級並宣佈了31美元的目標價。週三，ACADIA Pharmaceuticals的股價下跌了0.6％，收於15.50美元。請查看其他分析師對此股票的看法。
- Mizuho分析師Wei Fang發起了對Grab Holdings Limited（納斯達克：GRAB）的覆蓋，給出了超額表現評級並宣佈了5美元的目標價。週三，Grab的股價下跌了0.3％，收於3.51美元。請查看其他分析師對此股票的看法。
- Redburn Atlantic分析師Steve Chesney發起了對Vertex Pharmaceuticals Incorporated（納斯達克：VRTX）的覆蓋，給出了買入評級並宣佈了545美元的目標價。週三，Vertex Pharmaceuticals的股價上漲了0.1％，收於474.00美元。請查看其他分析師對此股票的看法。請查看其他分析師對此股票的看法。
- Stephens＆Co.分析師Mason Carrico發起了對Hologic，Inc.（納斯達克：HOLX）的覆蓋，給出了超配評級並宣佈了87美元的目標價。週三，Hologic的股價上漲了0.9％，收於72.27美元。請查看其他分析師對此股票的看法。
- Oppenheimer分析師Ian Zaffino發起了對Kyndryl Holdings，Inc.（紐約證券交易所：KD）的覆蓋，給出了超額表現評級並宣佈了33美元的目標價。週三，Kyndryl的股價下跌了1％，收於25.28美元。請查看其他分析師對此股票的看法。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。